Dr.MasayukiKuroda Japan

Masayuki Kuroda, Ph.D., is a biomedical scientist specializing in gene therapy, cell engineering, and translational medicine. He earned his Ph.D. in Pharmaceutical Sciences from Okayama University in 1993, where he conducted research in microbiology and acquired foundational expertise in molecular and cellular biology. He subsequently trained at Harvard Medical School and Wayne State University School of Medicine, further strengthening his background in molecular biology and gene regulation. Upon returning to Japan, Dr. Kuroda joined Kochi Medical School (later reorganized as Kochi University), where his research shifted toward virology and the development of viral therapeutic vectors, marking the beginning of his long-standing involvement in gene therapy technologies. In addition to his work in virology, he contributed to education and broader microbiological research within the department. He later transitioned to CellGenTech, Inc. as a Manager, participating in the development of cell-based therapeutic platforms. Since 2007, Dr. Kuroda has been affiliated with Chiba University in the fields of clinical gene medicine and cellular therapeutics. He currently serves as an Associate Professor at the Center for Advanced Medicine, Chiba University Hospital. Dr. Kuroda’s current research focuses on engineering therapeutic cells—particularly ex vivo gene/cell therapy using adipocytes—to establish sustained in vivo delivery systems for bioactive molecules such as enzymes and metabolites. His work harnesses the unique biological features of adipocytes, including their long-term survival, metabolic stability, high secretory capacity, and favorable safety profile. By integrating adipocyte engineering with translational research, he aims to develop next-generation therapies for rare genetic diseases and metabolic disorders.